Skip to content
OpenCapital
Get started

Sagimet Biosciences SGMT Q4 2025 Annual earnings

Reported March 11, 2026 · Before market open

Diluted EPS-$0.29Beat by $0.14
Revenue estimate$1.1M
EPS estimate-$0.43

Next report

Aug 12, 2026 (In 4 weeks)
EPS estimate-$0.28

Versus estimates

Diluted EPS

Q1 2026-$0.33Beat by $0.06
Q4 2025-$0.29Beat by $0.14
Q3 2025-$0.40Beat by $0.01Q2 2025-$0.32Beat by $0.20Q1 2025-$0.56Beat by $0.23Q4 2024-$0.50Beat by $0.15

Ask the moment Sagimet Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Sagimet Biosciences report Q4 2025 earnings?
Sagimet Biosciences (SGMT) reported Q4 2025 earnings on March 11, 2026 before market open.
What were Sagimet Biosciences's Q4 2025 revenue and EPS?
Sagimet Biosciences reported diluted EPS of $-0.29 for Q4 2025.
Did Sagimet Biosciences beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.43 by $0.14.
How did Sagimet Biosciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 42.0% from $-0.50.
Where can I find Sagimet Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-026146) and the 10-K periodic report (0001104659-26-026140) directly on SEC EDGAR. The filing index links above go to sec.gov.